EndocrinologyIntermediate

FRAX® 10-Year Osteoporotic Fracture Risk Tool

Estimates 10-year probability of major osteoporotic and hip fractures.

Clinical Parameters

12 Variables

Awaiting Clinical Parameters

Configure the patient variables on the left and select Calculate Result to generate the clinical score and stratification.

Verified 2026 GuidelinesInstant Calculation
Jump to Formula & Clinical Protocol ↓
Advertisement
High Yield Prometric TopicEndocrinology & Metabolism

Tested on Gulf Medical Boards (DHA, SMLE, MOH & HAAD)

Clinical calculations and diagnostic scoring systems like FRAX® 10-Year Osteoporotic Fracture Risk Tool frequently appear on Prometric exams. Master high-yield clinical vignettes with instant AI-powered pathophysiology rationales.

Clinical Significance & Diagnostic Standard
2026 Clinical Reference

What is the FRAX® 10-Year Osteoporotic Fracture Risk Tool?

📋Clinical Summary & Definition Capsule

The FRAX® 10-Year Osteoporotic Fracture Risk Tool is an evidence-based clinical decision rule engineered to quantify diagnostic probability, stratify clinical severity, and guide therapeutic decision-making in endocrinology & metabolism practice. The WHO Fracture Risk Assessment Tool (FRAX®) integrates clinical risk factors with or without femoral neck bone mineral density (BMD) to calculate a patient’s 10-year probability of a major osteoporotic fracture and hip fracture to guide pharmacologic therapy decisions. Clinical scoring tools like FRAX® 10-Year Osteoporotic Fracture Risk Tool are essential in acute and outpatient management, enabling clinicians to objectively differentiate between low-risk candidates suitable for conservative therapy and high-risk patients requiring urgent interventions. Verified against current 2026 clinical standards, this tool is extensively tested on Gulf health authority licensing exams including DHA (Dubai), SMLE (Saudi Arabia), MOH, HAAD/DOH (Abu Dhabi), OMSB (Oman), and QCHP (Qatar).

💡Clinical Pearls & Diagnostic Utility

Empowers clinicians to initiate osteoporosis medications based on absolute fracture probability rather than BMD T-scores alone.

Mathematical Formulation

Formula & Calculation Parameters

The mathematical equation and clinical variables required to calculate FRAX® 10-Year Osteoporotic Fracture Risk Tool:

Cox proportional hazards regression integrating clinical fracture risk factors with optional femoral neck BMD T-score.
Risk Stratification

Score Interpretation & Clinical Stratification

Score RangeClinical InterpretationRisk Tier
≤ 19.9Below Major Osteoporotic Threshold (< 20%)green
≥ 20High Risk / Treatment Threshold Exceeded (≥ 20%)red
Clinical Limitations & Contraindications

When to Exercise Caution

Does not account for multiple prior fractures, higher-dose glucocorticoids, or spine vs. hip discordance; does not include fall history.

Sponsored Content
Medical Review & Guidelines Compliance
MD

Clinical Review Board

Dr. Muhammad Nouman, MBBS

Capital Medical University | PMDC Reg No: 117744-P

Clinical Audit Status

✓ Verified for 2026 Guidelines

Last updated: 2026-08-07

Peer-Reviewed Medical Literature

  • Kanis JA, et al. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19(4):385-397.
  • Cosman F, et al. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014;25(10):2359-2381.
Advertisement